The pharmaceutical industry is witnessing a transformative shift with the increasing adoption of biosimilars, particularly in the realm of monoclonal antibody treatments. Among these, Remicade biosimilars have emerged as vital alternatives in managing chronic inflammatory diseases, including rheumatoid arthritis, Crohn's disease, and psoriasis. The surge in demand for cost-effective b... https://www.feedsfloor.com/other/remicade-biosimilars-expanding-access-autoimmune-disease-treatment